Gene · 4287
Papers3,790
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,790
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nomogram Based on A-To-I RNA Editing for Predicting Overall Survival in Patients With Breast Cancer. | J Cell Mol Med | 2025 | 40995818 | PubTator, text mining | PubMed |
| Ocular Motor and Vestibular Profile in Spinocerebellar Ataxia Type 27B: Toward a Practical Bedside Diagnostic Framework. | Cerebellum | 2025 | 40906330 | PubTator, text mining | PubMed |
| Long-Term Effects of Annual Intensive Rehabilitation in Patients with Hereditary Pure Cerebellar Ataxia: A 7-year Follow-up Study. | Cerebellum | 2025 | 40906249 | PubTator, text mining | PubMed |
| The Case of Spinocerebellar Ataxias in Amazonas (Northern Brazil): An Analysis of Disease Frequency from a Geographic, Historical, and Genetic-Evolutionary Perspective. | Cerebellum | 2025 | 40900235 | PubTator, text mining | PubMed |
| Long-read sequencing identifies ATXN3 repeat expansions, and transcriptomics reveals disease progression biomarkers and druggable targets for spinocerebellar ataxia type 3. | BMC Neurol | 2025 | 40890629 | PubTator, text mining | PubMed |
| Content Validity of the Spinocerebellar Ataxia Composite Score as a Measure of Disease Progression in Patients with Spinocerebellar Ataxia. | Cerebellum | 2025 | 40888983 | PubTator, text mining | PubMed |
| m6A modulates RAN translation from CAG repeat expansion RNA. | Aggregate (Hoboken) | 2025 | 40880681 | PubTator, text mining | PubMed |
| Regulation of cisplatin resistance in lung cancer by epigenetic mechanisms. | Clin Epigenetics | 2025 | 40851017 | PubTator, text mining | PubMed |
| Episodic transport of protein aggregates achieves a positive size selectivity in aggresome formation. | Nat Commun | 2025 | 40846843 | PubTator, text mining | PubMed |
| Dysarthria in Spinocerebellar Ataxia Type 3: Prevalence and Disease Progression. | J Speech Lang Hear Res | 2025 | 40844917 | PubTator, text mining | PubMed |
| Prevalence, Severity, and Progression of Cerebellar Cognitive-Affective Syndrome in Patients With Spinocerebellar Ataxias. | Neurology | 2025 | 40834346 | PubTator, text mining | PubMed |
| The Hsp40 co-chaperone DNAJC7 modifies polyglutamine but not polyglycine aggregation. | bioRxiv | 2025 | 40832276 | PubTator, text mining | PubMed |
| Familial spinocerebellar ataxia type 3: A case report of multi-generational presentation. | Medicine (Baltimore) | 2025 | 40797466 | PubTator, text mining | PubMed |
| Neuroanatomical mapping of huntingtin-associated protein 1 across the rostral and caudal clusters of mouse raphe nuclei and its immunohistochemical relationships with serotonin. | Front Neuroanat | 2025 | 40766770 | PubTator, text mining | PubMed |
| Differential impact of mutant Ataxin-3 in hindbrain regions: further evidence of white matter loss as a core pathological feature. | Exp Neurol | 2025 | 40754098 | PubTator, text mining | PubMed |
| Comprehensive assessment of adverse event profiles associated with bispecific antibodies in multiple myeloma. | Blood Cancer J | 2025 | 40750760 | PubTator, text mining | PubMed |
| Comprehensive identification of pathogenic tandem repeat expansions in sporadic amyotrophic lateral sclerosis: advantages of long-read vs. short-read sequencing. | Exp Biol Med (Maywood) | 2025 | 40746751 | PubTator, text mining | PubMed |
| Magnetic resonance imaging for spinocerebellar ataxia: a bibliometric analysis based on web of science. | Front Neurol | 2025 | 40734822 | PubTator, text mining | PubMed |
| ATXN3 regulates lysosome regeneration after damage by targeting K48-K63-branched ubiquitin chains. | EMBO J | 2025 | 40730717 | PubTator, text mining | PubMed |
| Gene editing for Spinocerebellar ataxia type 3 taking advantage of the human ATXN3L paralog as replacement gene. | Gene Ther | 2025 | 40721863 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4287/papers?page=5